- CEO
- Dong-Won Lee
- Full Time Employees
- 197
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Seoul South Korea
- IPO Date
- May 4, 2016
- Business
- OSTEONIC Co., Ltd. is a South Korea-based medical device manufacturer specializing in the development, design, and commercialization of surgical implants, biomaterials, and precision orthopedic fixation systems. Founded in 2012 and headquartered in Seoul, South Korea, the company operates across five core medical sectors: Cranio-Maxillofacial (CMF), Trauma and Extremities, Sports Medicine, Spine, and Dental surgery. OSTEONIC offers a comprehensive range of metal and biodegradable polymer implants, including the Optimus CMF System and Biobsorb Plating System for cranial, mandibular, orthognathic, and facial reconstructive surgery; the SIGNEX and Quantum Trauma Systems, comprising anatomically contoured titanium locking and non-locking compression plates, cannulated screws, and headless compression screws for upper and lower extremity fractures, hand, wrist, clavicle, foot, and ankle stabilization; the Kinex Sports Medicine portfolio, featuring biodegradable composite suture anchors, interference screws, and tendon-to-bone fixation devices for ligament repair; Anterior Cervical Plating (ACP) and spinal fixation implants; the Optimus D dental fixation line, including palatal plates, mandible compression screws, and oral surgical kits; custom 3D-designed patient-specific cranial implants under the Real Fit brand; and specialized surgical instrumentation kits and screwdriver systems for orthopedic and reconstructive procedures. The company serves hospitals, surgical clinics, and healthcare networks globally across North America, Europe, the Asia-Pacific, and Latin America through proprietary brand distribution and international OEM/ODM partnerships with multinational medical corporations, including B. Braun Aesculap for neurosurgical plating systems and Zimmer Biomet for sports medicine implants. In recent developments, OSTEONIC expanded its strategic manufacturing and distribution partnership with Zimmer Biomet to develop and supply the Suture Passer surgical instrument, securing South Korean Ministry of Food and Drug Safety approval alongside U.S. FDA 510(k) submission for global commercialization. The company has also secured multiple FDA clearances across its trauma, spinal ACP, and biocomposite product portfolios and completed a significant manufacturing facility expansion to scale annual production capacity across both metal and bioabsorbable implant lines to meet expanding international export demand.